IBDEI0WK ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15004,1,4,0)
 ;;=4^I70.361
 ;;^UTILITY(U,$J,358.3,15004,2)
 ;;=^5007641
 ;;^UTILITY(U,$J,358.3,15005,0)
 ;;=I70.362^^85^807^14
 ;;^UTILITY(U,$J,358.3,15005,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15005,1,3,0)
 ;;=3^Athscl of Unspec Bypass,Left Leg w/ Gangrene
 ;;^UTILITY(U,$J,358.3,15005,1,4,0)
 ;;=4^I70.362
 ;;^UTILITY(U,$J,358.3,15005,2)
 ;;=^5007642
 ;;^UTILITY(U,$J,358.3,15006,0)
 ;;=I70.363^^85^807^13
 ;;^UTILITY(U,$J,358.3,15006,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15006,1,3,0)
 ;;=3^Athscl of Unspec Bypass,Bilateral Legs w/ Gangrene
 ;;^UTILITY(U,$J,358.3,15006,1,4,0)
 ;;=4^I70.363
 ;;^UTILITY(U,$J,358.3,15006,2)
 ;;=^5007643
 ;;^UTILITY(U,$J,358.3,15007,0)
 ;;=E10.52^^85^807^16
 ;;^UTILITY(U,$J,358.3,15007,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15007,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Prph Angiopathy w/ Gangrene
 ;;^UTILITY(U,$J,358.3,15007,1,4,0)
 ;;=4^E10.52
 ;;^UTILITY(U,$J,358.3,15007,2)
 ;;=^5002611
 ;;^UTILITY(U,$J,358.3,15008,0)
 ;;=E11.52^^85^807^17
 ;;^UTILITY(U,$J,358.3,15008,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15008,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Prph Angiopathy w/ Gangrene
 ;;^UTILITY(U,$J,358.3,15008,1,4,0)
 ;;=4^E11.52
 ;;^UTILITY(U,$J,358.3,15008,2)
 ;;=^5002651
 ;;^UTILITY(U,$J,358.3,15009,0)
 ;;=R13.19^^85^808^33
 ;;^UTILITY(U,$J,358.3,15009,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15009,1,3,0)
 ;;=3^Dysphagia NEC
 ;;^UTILITY(U,$J,358.3,15009,1,4,0)
 ;;=4^R13.19
 ;;^UTILITY(U,$J,358.3,15009,2)
 ;;=^335280
 ;;^UTILITY(U,$J,358.3,15010,0)
 ;;=R15.9^^85^808^40
 ;;^UTILITY(U,$J,358.3,15010,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15010,1,3,0)
 ;;=3^Full Incontinence of Feces
 ;;^UTILITY(U,$J,358.3,15010,1,4,0)
 ;;=4^R15.9
 ;;^UTILITY(U,$J,358.3,15010,2)
 ;;=^5019247
 ;;^UTILITY(U,$J,358.3,15011,0)
 ;;=D50.0^^85^808^51
 ;;^UTILITY(U,$J,358.3,15011,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15011,1,3,0)
 ;;=3^Iron Deficiency Anemia d/t Blood Loss
 ;;^UTILITY(U,$J,358.3,15011,1,4,0)
 ;;=4^D50.0
 ;;^UTILITY(U,$J,358.3,15011,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,15012,0)
 ;;=D50.9^^85^808^52
 ;;^UTILITY(U,$J,358.3,15012,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15012,1,3,0)
 ;;=3^Iron Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,15012,1,4,0)
 ;;=4^D50.9
 ;;^UTILITY(U,$J,358.3,15012,2)
 ;;=^5002283
 ;;^UTILITY(U,$J,358.3,15013,0)
 ;;=D62.^^85^808^5
 ;;^UTILITY(U,$J,358.3,15013,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15013,1,3,0)
 ;;=3^Acute Posthemorrhagic Anemia
 ;;^UTILITY(U,$J,358.3,15013,1,4,0)
 ;;=4^D62.
 ;;^UTILITY(U,$J,358.3,15013,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,15014,0)
 ;;=D64.9^^85^808^11
 ;;^UTILITY(U,$J,358.3,15014,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15014,1,3,0)
 ;;=3^Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,15014,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,15014,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,15015,0)
 ;;=E10.9^^85^808^27
 ;;^UTILITY(U,$J,358.3,15015,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15015,1,3,0)
 ;;=3^Diabetes Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,15015,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,15015,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,15016,0)
 ;;=E11.9^^85^808^28
 ;;^UTILITY(U,$J,358.3,15016,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15016,1,3,0)
 ;;=3^Diabetes Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,15016,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,15016,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,15017,0)
 ;;=E13.9^^85^808^29
 ;;^UTILITY(U,$J,358.3,15017,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15017,1,3,0)
 ;;=3^Diabetes w/o Complications NEC
